Suppr超能文献

雷尼替丁的N-2-(2-羟基-2-苯基)乙基-N''-(甲磺酰基)胍类似物的合成及抗溃疡活性。新型抗溃疡药物T-593的研发

[Synthesis and antiulcer activity of N-2-(2-hydroxy-2-phenyl)ethyl-N"-(methanesulfonyl)guanidine analogue of ranitidine. Development of a new antiulcer agent T-593].

作者信息

Shibata H, Kusayanagi Y, Arai H, Hashiba K, Yamamoto Y, Onoda M

机构信息

Research Laboratories, Toyama Chemical Co., Ltd., Japan.

出版信息

Yakugaku Zasshi. 1998 Mar;118(3):88-104. doi: 10.1248/yakushi1947.118.3_88.

Abstract

A series of the aryl-substituted N'-2-(2-hydroxy-2-phenyl)ethyl derivatives of N"-methanesulfonyl-N-2-((5-dimethylaminomethyl or 5-methylaminomethyl) furfurylthio)ethylguanidine have been synthesized as potential antisecretory and mucosal protective antiulcer agents. The synthetic routes involves, at the last stage, the reaction of 2-hydroxy-2-phenylethylamines with N-2-(furfurylthio)-ethyl-N'-methanesulfonyl-S-methylisothiourea or its O-phenylisourea counterpart. The primary screening test to assess the inhibitory activity of the synthetic compounds on histamine-induced gastric acid secretion was carried out in anesthetized rats by the lumen-perfusion technique of Ghosh and Schild and also by the pylorus-ligated preparation method. The best profile of histamine H2-antagonist activity was much better than that of the prototype ranitidine, and obtained with N'-(2-(2-hydroxy-2-(4-hydroxyphenyl)) ethyl-N"-methanesulfonyl-N-2-(5-(methylaminomethyl)furfurylthio)et hylguanidine (12f), which was also characterized by enhancing the gastric mucosal blood flow in rabbits as observed by the thermoelectric method. This compound 12f, designated as T-593, significantly inhibited the formation of the indomethacin-induced gastric lesions in rats; 3.5-fold more potent than ranitidine, but 4-fold less active than famotidine. On the other hand, T-593 and famotidine displayed comparable activities in healing the acetic acid-induced gastric ulcer with and without the dosing of indomethacin. Additional notable features of T-593, as determined in rats, are that its protective effect on the hemorrhagic shock-induced lesion under the prior dosing of histamine is ca. 10- and 2-fold greater than ranitidine and famotidine, respectively, and that a decrease in the gastric mucosal blood flow caused by a partial blood-withdrawal is more strongly recovered with T-593 than with famotidine. These experimental results suggest that the antiulcer efficacy of T-593 can be explained by its dual activities: antisecretion of gastric acid and, more importantly, protection of gastric mucous membrane.

摘要

一系列N”-甲磺酰基-N-2-((5-二甲基氨基甲基或5-甲基氨基甲基)糠硫基)乙基胍的芳基取代N'-2-(2-羟基-2-苯基)乙基衍生物已被合成,作为潜在的抗分泌和黏膜保护抗溃疡药物。合成路线在最后阶段涉及2-羟基-2-苯乙胺与N-2-(糠硫基)乙基-N'-甲磺酰基-S-甲基异硫脲或其O-苯基异脲类似物的反应。通过Ghosh和Schild的肠腔灌注技术以及幽门结扎制备方法,在麻醉大鼠中进行了评估合成化合物对组胺诱导的胃酸分泌抑制活性的初步筛选试验。组胺H2拮抗剂活性的最佳表现比原型雷尼替丁好得多,并且用N'-(2-(2-羟基-2-(4-羟基苯基))乙基-N”-甲磺酰基-N-2-(5-(甲基氨基甲基)糠硫基)乙基胍(12f)获得,通过热电法观察到该化合物还能增加兔胃黏膜血流量。这种化合物12f,命名为T-593,显著抑制吲哚美辛诱导的大鼠胃损伤的形成;效力比雷尼替丁高3.5倍,但活性比法莫替丁低4倍。另一方面,在有或没有给予吲哚美辛的情况下,T-593和法莫替丁在治愈乙酸诱导的胃溃疡方面表现出相当的活性。在大鼠中确定的T-593的其他显著特征是,在预先给予组胺的情况下,其对出血性休克诱导的损伤的保护作用分别比雷尼替丁和法莫替丁大10倍和2倍,并且与法莫替丁相比,T-593能更有效地恢复因部分失血引起的胃黏膜血流量减少。这些实验结果表明,T-593的抗溃疡功效可以通过其双重活性来解释:胃酸分泌抑制作用,更重要的是胃黏膜保护作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验